Download the Felix App
Earn reward, visit our shop and get exclusive offers on the app
Download now

Generic semaglutide contains the same active ingredient as Ozempic and Wegovy.
While we can't guarantee specific pricing, increased competition typically drives costs down across both brand-name and generic medications, and similar launches have seen prices drop by up to 65%.
We expect to make these available to Felix patients in the coming weeks.
What are generic drugs?
Generic medications are basically copies of brand name medications. They are authorized for sale by Health Canada to have the exact same active pharmaceutical ingredients and therapeutic effect as the original brand.
How do generics impact drug pricing?
In Canada, the government and generic manufacturers have a pricing framework in place that lowers the price of generics as more of them enter the market. Learn more about generic pricing framework here.
*Based on the current brand price of $320 per pen
Again, brand name prices are expected to drop as well as competition increases.
Can I trust generics if they’re cheaper?
Yes! Generic medications are strictly regulated by Health Canada to ensure they are just as safe, effective, and high-quality as the original brand-name drugs.
To be authorized for sale, generic medications must contain the same active ingredient, be the same strength, dosage, and form, work the same way in the body, and meet the same safety, quality, and manufacturing standards.
Who makes the first approved generic semaglutide?
The first generic semaglutide approved in Canada is manufactured by Dr. Reddy's Laboratories. Health Canada follows a rigorous review process to ensure generic medications contain the same active ingredient and meet the same safety, quality, and manufacturing standards as the original brand-name drug.
When will prices start to drop?
The first generic semaglutide was approved by Health Canada on April 28, 2026 (manufactured by Dr. Reddy's Laboratories). Eight additional generic submissions are currently under review.
Prices will likely fall in stages as more generic manufacturers enter the market. It may also take some time for these companies to scale up production, so availability could be limited at first or sporadic throughout the year depending on demand and production capacity. Coverage under provincial drug plans will vary by province and is not yet confirmed.
Will all Semaglutide-based drugs be impacted?
Because only semaglutide is going off-patent, lower prices are expected for semaglutide medications, but not necessarily others.